Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
17 Oct 2026, 2:00 pm7d left
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Published by the portal on this tender, for queries and grievance redressal.
CREMAFFIN LIQUID PARAFFIN 1.25 MG PLUS MAGNESIUM HYDROXIDE 3.75 MG PLUS SODIUM PICOSULPHATE 3.3 MG 170ML SYP
PIRACETAM 800 MG TAB
THYROXIN 150 MCG TAB
GLYCERIN BOTT OF 100 ML
PHENOBARBITONE 30 MG TAB
9917087
GEM/2026/B/8057676
Two Packet Bid
CREMAFFIN LIQUID PARAFFIN 1.25 MG PLUS MAGNESIUM
Mumbai, Maharashtra
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1.1 L
₹1 L
20%
Exempted
Yes
7 Oct 2026
7 Oct 2026
18 Oct 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | CREMAFFIN LIQUID PARAFFIN 1.25 MG PLUS MAGNESIUM HYDROXIDE 3.75 MG PLUS SODIUM PICOSULPHATE 3.3 MG 170ML SYP | 4,740 | BOTT | Mumbai | 30 |
| 2 | PIRACETAM 800 MG TAB | 5,400 | PIECES | Mumbai | 30 |
| 3 | THYROXIN 150 MCG TAB | 6,000 | PIECES | Mumbai | 30 |
| 4 | GLYCERIN BOTT OF 100 ML | 900 | BOTT | Mumbai | 30 |
| 5 | PHENOBARBITONE 30 MG TAB | 4,800 | PIECES | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9917087.pdf
GEM_BID • 0.14 MB
bbqrcrema_2026-09-19-12-23-10_d6ba9638d8ff0390b3b48abb8d01dc0c.pdf
BOQ • 0.14 MB
boqcremafin_2026-09-19-12-23-10_49d35e04af0614201df1679b0084ceae.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .